Navegar

Colección

Datos Estadísticas

Lista de

doxorubicin
25
"Synthesis and cytotoxicity evaluation of A-ring derivatives of cycloartanone" (2017) Zambrano, E.E.;Casas, A.G.;Di Venosa, G.M. (...)Palermo, J.A. Phytochemistry Letters. 21:200-205
"Phytochemical Study of the Genus Salpichroa (Solanaceae), Chemotaxonomic Considerations, and Biological Evaluation in Prostate and Breast Cancer Cells" (2017) Basso, A.V.;Leiva González, S.;Barboza, G.E. (...)Nicotra, V.E. Chemistry and Biodiversity. 14(8)
"Mdm2 promotes Cdc25C protein degradation and delays cell cycle progression through the G2/M phase" (2017) Giono, L.E.;Resnick-Silverman, L.;Carvajal, L.A. (...)Manfredi, J.J. Oncogene. 36(49):6762-6773
"Mdm2 promotes Cdc25C protein degradation and delays cell cycle progression through the G2/M phase" (2017) Giono, L.E.;Resnick-Silverman, L.;Carvajal, L.A. (...)Manfredi, J.J. Oncogene. 36(49):6762-6773
"Association of HO-1 and BRCA1 is critical for the maintenance of cellular homeostasis in prostate cancer" (2015) Labanca, E.;De Luca, P.;Gueron, G. (...)De Siervi, A. Molecular Cancer Research. 13(11):1455-1464
"Dynamic coregulatory complex containing BRCA1, E2F1 and CtIP controls ATM transcription" (2012) Moiola, C.;De Luca, P.;Cotignola, J. (...)De Siervi, A. Cellular Physiology and Biochemistry. 30(3):596-608
"Dynamic coregulatory complex containing BRCA1, E2F1 and CtIP controls ATM transcription" (2012) Moiola, C.;De Luca, P.;Cotignola, J. (...)De Siervi, A. Cellular Physiology and Biochemistry. 30(3):596-608
"FKBP51 and FKBP52 in signaling and disease" (2011) Storer, C.L.;Dickey, C.A.;Galigniana, M.D. (...)Cox, M.B. Trends in Endocrinology and Metabolism. 22(12):481-490
"ROS production by endogenously generated protoporphyrin IX in murine leukemia cells" (2009) Diez, B.;Cordo Russo, R.;Teijo, M.J. (...)Fukuda, H. Cellular and Molecular Biology. 55(2):15-19
"p21 modulates threshold of apoptosis induced by DNA-damage and growth factor withdrawal in prostate cancer cells" (2002) Martinez, L.A.;Yang, J.;Vazquez, E.S. (...)Navone, N.M. Carcinogenesis. 23(8):1289-1296
"Interferon-alpha 2b modulation of doxorubicin sensitivity in a multidrug resistant cell line" (2001) Gritti, M.F.L.; Beviacqua, M.; Bordenave, R.H.; Rumi, L.S. Journal of Experimental and Clinical Cancer Research. 20(3):393-400
"Interferon-alpha 2b modulation of doxorubicin sensitivity in a multidrug resistant cell line" (2001) Gritti, M.F.L.; Beviacqua, M.; Bordenave, R.H.; Rumi, L.S. Journal of Experimental and Clinical Cancer Research. 20(3):393-400
"Reactivity of monoclonal antibody FC-2.15 against drug resistant breast cancer cells. Additive cytotoxicity of adriamycin and taxol with FC-2.15" (1998) Ballaré, C.;Portela, P.;Schiaffi, J. (...)Mordoh, J. Breast Cancer Research and Treatment. 47(2):163-170
"Reactivity of monoclonal antibody FC-2.15 against drug resistant breast cancer cells. Additive cytotoxicity of adriamycin and taxol with FC-2.15" (1998) Ballaré, C.;Portela, P.;Schiaffi, J. (...)Mordoh, J. Breast Cancer Research and Treatment. 47(2):163-170
"Enhancement of aminolevulinic acid based photodynamic therapy by adriamycin" (1997) Casas, A.; Fukuda, H.; Riley, P.; Del C. Batlle, A.M. Cancer Letters. 121(1):105-113
"Enhancement of aminolevulinic acid based photodynamic therapy by adriamycin" (1997) Casas, A.; Fukuda, H.; Riley, P.; Del C. Batlle, A.M. Cancer Letters. 121(1):105-113
"Adriamycin effects on hydroperoxide metabolism and growth of human breast tumor cells" (1990) Bustamante, J.; Galleano, M.; Medrano, E.E.; Boveris, A. Breast Cancer Research and Treatment. 17(2):145-153
"Adriamycin effects on hydroperoxide metabolism and growth of human breast tumor cells" (1990) Bustamante, J.; Galleano, M.; Medrano, E.E.; Boveris, A. Breast Cancer Research and Treatment. 17(2):145-153
"Mitoxantrone affects topoisomerase activities in human breast cancer cells" (1986) Crespi, M.D.; Ivanier, S.E.; Genovese, J.; Baldi, A. Biochemical and Biophysical Research Communications. 136(2):521-528
"Sequential methotrexate, 5-fluorouracil (high-dose), and doxorubicin for advanced gastric cancer" (1986) Muro, H.;Acuña, L.R.;Castagnari, A. (...)Marantz, A. Cancer Treatment Reports. 70(11):1333-1334
"Sequential methotrexate, 5-fluorouracil (high-dose), and doxorubicin for advanced gastric cancer" (1986) Muro, H.;Acuña, L.R.;Castagnari, A. (...)Marantz, A. Cancer Treatment Reports. 70(11):1333-1334